Undp Chad Pharmaceutical Import Profile — Chad (DGFT 2022–2026)

Name: Undp Chad Pharmaceutical Import Records from India — 2 Products, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Undp Chad — Pharmaceutical Importer Profile (2026) | 2 Products, $400.0K Trade | TransData Nexus

Undp Chad

Pharmaceutical Importer · Chad · Antimalarial & Antiparasitic Focus · $400.0K Total Trade · DGFT Verified

Undp Chad is a pharmaceutical importer based in Chad with a total trade value of $400.0K across 2 products in 1 therapeutic categories. Based on 8 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Undp Chad sources from 1 verified Indian supplier, with Macleods Pharmaceuticals Limited accounting for 100.0% of imports.

Undp Chad — Import Portfolio & Supplier Network

Undp Chad import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Undp Chad?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$200.0K	4	100.0%

Undp Chad sources from 1 verified Indian supplier across 2 distinct formulations. The sourcing is highly concentrated — Macleods Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Undp Chad Import?

Formulation	Value	Ships
Medicines amodiaquine as hydrochloride dispersible tablets sulfadoxine pyrimethamine dispersible	$150.0K	3
Medicines amodiaquine as hydrochloride dispersible tablets sulfadoxine pyrimethamine dispersible tablets	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pyrimethamine	Antimalarial & Antiparasitic	$200.0K	4	0.4%	10
2	Sulfadoxine	Antimalarial & Antiparasitic	$200.0K	4	0.4%	9

Undp Chad imports 2 pharmaceutical products across 1 categories into Chad totaling $400.0K.

Undp Chad — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Undp Chad is a pharmaceutical importer and buyer based in Chad, specializing in the procurement of finished pharmaceutical formulations. As a United Nations Development Programme (UNDP) office, it plays a pivotal role in sourcing essential medicines to support healthcare initiatives within the country. The organization operates under the auspices of the UNDP, which is renowned for its global efforts in promoting sustainable development and humanitarian assistance. In Chad, the UNDP collaborates with various stakeholders to enhance healthcare delivery, particularly in the procurement and distribution of medical supplies.

In the period from 2022 to 2026, Undp Chad imported a total of $400,000 USD worth of pharmaceutical products from India, comprising eight shipments. The imported products were exclusively finished pharmaceutical formulations, including tablets and capsules, indicating a focus on ready-to-use medications rather than raw active pharmaceutical ingredients (APIs). This sourcing strategy aligns with the UNDP's commitment to ensuring the availability of quality-assured medicines for health programs in Chad.

2Distribution Network

While specific details about Undp Chad's warehouse locations and logistics capabilities are not publicly disclosed, as a UNDP office, it is likely to collaborate with established logistics partners to ensure efficient distribution of medical supplies. The UNDP typically engages in partnerships with local and international logistics providers to facilitate the timely delivery of health products to various regions within Chad. This approach ensures that essential medicines reach healthcare facilities and communities in need, supporting the broader objectives of the UNDP's health initiatives in the country.

3Industry Role

Undp Chad functions as a key player in the pharmaceutical supply chain within the country, primarily acting as a buyer and importer of essential medicines. Its role is distinct from that of a wholesaler or distributor, as it focuses on sourcing and importing finished pharmaceutical formulations to support health programs. By procuring medicines from reputable suppliers, such as Indian pharmaceutical manufacturers, Undp Chad ensures the availability of quality-assured products for healthcare providers and patients across Chad.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Undp Chad

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Undp Chad's sourcing strategy exhibits a high degree of concentration, with all imported pharmaceutical products originating from a single supplier, MACLEODS PHARMACEUTICALS LIMITED, India. This single-source dependency may present risks, such as supply chain disruptions or price fluctuations. However, it could also reflect a strategic choice aimed at ensuring consistency in product quality and supply reliability. The stability of this relationship is crucial, and any changes in the supplier's production capacity or export policies could significantly impact Undp Chad's ability to meet its procurement needs.

2Supply Chain Resilience

The resilience of Undp Chad's supply chain is closely tied to the stability and reliability of its sole supplier, MACLEODS PHARMACEUTICALS LIMITED. Given the absence of backup suppliers, any disruptions in the supplier's operations could pose challenges. The focus on finished pharmaceutical formulations indicates a preference for ready-to-use products, which may limit the flexibility to switch suppliers or adapt to alternative sourcing strategies. Ensuring that MACLEODS PHARMACEUTICALS LIMITED adheres to international quality standards and maintains consistent production and export capabilities is essential for the uninterrupted supply of medicines to Chad.

Strategic Implications

Importing Pharmaceuticals into Chad — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Chad

1Regulatory Authority & Framework

In Chad, the General Directorate of Pharmacy, Medicines, and Laboratories (DGPML) serves as the National Pharmaceutical Regulatory Authority (NPRA), overseeing the regulation and control of pharmaceutical products. The DGPML is responsible for ensuring that all imported medicines meet the country's quality standards and regulatory requirements. The legal framework governing pharmaceutical imports includes various decrees and orders that stipulate procedures for granting import authorizations and conducting quality controls. For instance, public health facilities are required to obtain supplies from establishments under the supervision of the Ministry of Health, and the importation of medicines is subject to prior authorization by health authorities.

2Import Licensing & GMP

Import licensing in Chad is regulated by specific decrees that outline the procedures for granting special import authorizations for certain products. These regulations ensure that imported pharmaceutical products comply with national standards and are subject to quality controls. Good Manufacturing Practice (GMP) certificates from recognized authorities, such as the World Health Organization (WHO), are typically required to demonstrate that products meet international quality standards. Importers must adhere to these licensing requirements and ensure that their products are accompanied by the necessary certifications to facilitate smooth customs clearance and distribution within Chad.

Undp Chad — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Undp Chad's focus on importing antimalarial and antiparasitic medications, specifically Pyrimethamine and Sulfadoxine, reflects the high prevalence of malaria and other parasitic diseases in the region. The demand for these treatments is driven by the need to control and eliminate malaria, a leading cause of morbidity and mortality in Chad. By sourcing these essential medicines, Undp Chad supports national health initiatives aimed at reducing the burden of infectious diseases and improving public health outcomes.

2Sourcing Profile

Undp Chad's sourcing strategy emphasizes the procurement of generic antimalarial and antiparasitic formulations, primarily from India. This approach leverages India's robust pharmaceutical manufacturing sector, known for producing high-quality generic medicines at competitive prices. By focusing on finished formulations, Undp Chad ensures the availability of ready-to-use treatments that meet international quality standards, facilitating efficient distribution and administration within Chad's healthcare system.

3Market Positioning

Undp Chad serves a critical role in the public health sector, acting as a primary supplier of essential antimalarial and antiparasitic medications. Its imports are directed towards government health programs, clinics, and hospitals, ensuring that these institutions have access to necessary treatments. By focusing on the public sector, Undp Chad contributes to the broader goal of improving healthcare accessibility and affordability for the population.

Seller's Guide — How to Become a Supplier to Undp Chad

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a potential opportunity to become alternative partners for Undp Chad, especially if they can offer competitive pricing, consistent supply, and adherence to international quality standards. However, the existing single-source dependency on MACLEODS PHARMACEUTICALS LIMITED may present challenges in establishing new partnerships. Suppliers would need to demonstrate reliability and compliance with Chad's regulatory requirements to be considered viable alternatives.

2Requirements & Qualifications

Indian exporters aiming to supply Undp Chad must ensure that their products are manufactured in facilities compliant with WHO Good Manufacturing Practice (GMP) standards. Products should be accompanied by necessary certifications, including GMP certificates and quality assurance documents, to facilitate import licensing and customs clearance in Chad. Additionally, labeling must be in French, and products should meet any serialization requirements mandated by Chadian regulations.

3How to Approach

Frequently Asked Questions — Undp Chad

What products does Undp Chad import from India?

Undp Chad imports 2 pharmaceutical products across 1 categories. Top imports: Pyrimethamine ($200.0K), Sulfadoxine ($200.0K).

Who supplies pharmaceuticals to Undp Chad from India?

Undp Chad sources from 1 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (100.0% of imports, $200.0K).

What is Undp Chad's total pharmaceutical import value?

Undp Chad's total pharmaceutical import value from India is $400.0K, based on 8 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Undp Chad focus on?

Undp Chad imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Undp Chad Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.